2 Information about rivaroxaban
|
Marketing authorisation indication |
Rivaroxaban (Xarelto, Bayer), co-administered with aspirin, is indicated for 'the prevention of atherothrombotic events in adult patients with coronary artery disease or symptomatic peripheral artery disease at high risk of ischaemic events'. |
|---|---|
|
Dosage in the marketing authorisation |
The recommended dosage for rivaroxaban is 2.5 mg taken orally twice daily in combination with a daily dose of 75 to 100 mg aspirin taken orally. |
|
Price |
The list price for 56 tablets of rivaroxaban 2.5 mg is £50.40 (company submission). The treatment period is indefinite. |